Company Overview and News

 
MSM - Cancellation Notice

2017-07-24 londonstockexchange
Listing and trading of the under mentioned security has been cancelled with effect from 21st July 2017.

 
Indag Rubber's 9M FY17 highlights

2017-01-16 indiainfoline
The Khemka Group promoted, Indag Rubber had a remarkable nine quarters. On the financial front the company posted remarkable numbers in 9M FY17. Revenue of the company stands at Rs 139.3 crore. EBITDA too has come in strong at 25.7 crore. PAT in these nine months stands at Rs 16.4 crore.

 
Indag Rubber down 4% on poor Q3 result

2017-01-16 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

 
Stocks in news: Fortis, Coal India, DHFL, Sical Log, DCB Bank

2017-01-16 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

 
Board of Indag Rubber to consider Q3 and 9M results

2017-01-03 indiainfoline
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

 
Indag Rubber standalone net profit declines 24.88% in the September 2016 quarter

2016-10-24 indiainfoline
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

 
Stocks to watch: Axis, Wipro, Mindtree, Cairn, Lakshmi Machine

2016-10-22 moneycontrol
Axis Bank | Sun Pharma | Wipro | Mindtree | Mahindra and Mahindra | Cairn India | V-Guard Industries | Tata Sponge | RPG Life and Lakshmi Machine Works are stocks, which will be in the news on Monday.

 
Indag Rubber standalone net profit declines 27.90% in the June 2016 quarter

2016-08-10 indiainfoline
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

 
Stocks in news: Tata Motors, HDFC, Lupin, Idea, Max Fin, Cadila

2016-08-09 moneycontrol
Tata Motors | HDFC | Lupin | Idea Cellular | Max Financial | Mukand | Nitin Fire | Subros | Cadila | Jindal Steel | Arvind | SRF and HOEC are stocks, which are in the news today.

 
Indag Rubber standalone net profit declines 19.41% in the March 2016 quarter

2016-04-16 indiainfoline
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.

 
Indag Rubber standalone net profit rises 3.10% in the December 2015 quarter

2016-02-22 indiainfoline
Sales rise 4.16% to Rs 62.16 crore

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...